We think differently about mental health so you can too
Our vision is a world of mental wellbeing.
COMPASS is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first programme is researching how psilocybin therapy could help people with treatment-resistant depression.
We want to transform the patient experience in mental health care.
Everyone has a mental health story, be it their own, or that of a friend or loved one. Our people bring their stories, and a wide range of backgrounds and skills to COMPASS.
Our research is evidence-based and underpinned by a commitment to find better ways to support and empower people suffering with poor mental health.
News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology, and digital platforms.
- COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
- COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021
- COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder